Envestnet Asset Management Inc. cut its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 4.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,786,402 shares of the enterprise software provider's stock after selling 194,399 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.14% of Oracle worth $529,377,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the company. Redmont Wealth Advisors LLC acquired a new stake in Oracle in the 1st quarter worth about $27,000. Inlight Wealth Management LLC acquired a new position in shares of Oracle during the 1st quarter valued at about $28,000. Sunbeam Capital Management LLC purchased a new position in shares of Oracle during the 4th quarter worth about $30,000. Hurley Capital LLC acquired a new stake in shares of Oracle in the fourth quarter worth approximately $33,000. Finally, Mpwm Advisory Solutions LLC purchased a new stake in Oracle in the fourth quarter valued at approximately $36,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Insider Activity at Oracle
In other Oracle news, Director Naomi O. Seligman sold 2,866 shares of the firm's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the transaction, the director owned 31,764 shares of the company's stock, valued at approximately $4,749,670.92. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Clayton M. Magouyrk sold 15,000 shares of the stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the completion of the transaction, the insider owned 60,722 shares of the company's stock, valued at $13,000,580.20. This trade represents a 19.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 440,366 shares of company stock worth $83,103,603. 42.20% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several equities analysts recently commented on ORCL shares. Westpark Capital upped their price target on shares of Oracle from $195.00 to $246.00 and gave the stock a "buy" rating in a research report on Thursday, June 12th. KeyCorp increased their target price on Oracle from $200.00 to $225.00 and gave the stock an "overweight" rating in a research report on Thursday, June 12th. Guggenheim lifted their target price on Oracle from $220.00 to $250.00 and gave the company a "buy" rating in a report on Wednesday, June 18th. Morgan Stanley restated an "overweight" rating on shares of Oracle in a research note on Wednesday, June 18th. Finally, TD Cowen lifted their price objective on Oracle from $250.00 to $275.00 and gave the company a "buy" rating in a research note on Thursday. Ten research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $204.15.
Read Our Latest Stock Analysis on Oracle
Oracle Stock Performance
NYSE:ORCL traded down $5.02 during mid-day trading on Monday, hitting $232.30. The stock had a trading volume of 16,061,923 shares, compared to its average volume of 10,185,327. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 4.07. The company has a 50 day simple moving average of $178.14 and a 200-day simple moving average of $164.22. The stock has a market capitalization of $652.49 billion, a price-to-earnings ratio of 53.53, a P/E/G ratio of 3.55 and a beta of 1.39. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $237.99.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. The business had revenue of $15.90 billion during the quarter, compared to analyst estimates of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The business's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.63 EPS. On average, research analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, July 10th. Oracle's dividend payout ratio is currently 46.08%.
Oracle Company Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.